Document is current
Any future updates will be listed below
-
Authors
Torres-Villaros, Héloïse https://orcid.org/0000-0002-5090-7845
Giocanti-Aurégan, Audrey
Doan, Serge
Agard, Emilie
Billant, Jérémy
Arbousoff, Nathalie
Matagrin, Benjamin
Fenniri, Inès
Dot, Corinne
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06174181 at ClinicalTrials.govDocuments that mention this clinical trial
Continuous versus Intermittent Use of Tear Substitutes in Patients Treated with Anti-VEGF for Neovascular Age-Related Macular Degeneration: The TREDIA Study
https://doi.org/10.1007/s40123-025-01201-3
- License Information
-
More Information
Article History
Received: 6 February 2025
Accepted: 26 June 2025
First Online: 22 July 2025
Declarations
:
: Héloïse Torres-Villaros, Emilie Agard, Jérémy Billant, Benjamin Matagrin, Nathalie Arbousoff, and Inès Fenniri declare that they have no competing interests; Serge Doan reports receiving personal fees from Bausch&Lomb, Horus Pharma, Quantel Medical, Santen, and Théa; Audrey Giocanti-Aurégan reports receiving personal fees from Abbvie, Apellis, Bayer, Horus Pharma, Roche, Novartis, and Théa; Corinne Dot reports receiving personal fees from Abbvie, Bayer, Horus Pharma, Novartis, and Roche.
: All patients received information on the study and signed a consent form to participate in the study. This study was conducted in accordance with the tenets of the Declaration of Helsinki. It obtained a favorable opinion from our institutional review board (ID-RCB no. 2023-A00620-45; Comité de Protection des Personnes Ouest II, France) according to the principles of Jarde law no. 2012–300, including the decrees of 23 December 2023, on Research Involving the Human Person (called RIPH in French). Data were collected and processed in accordance with the MR-003 reference methodology. The IRB approval covered both study sites.
: The manuscript was linguistically reviewed by Mrs. Sophie Pegorier, a native English-speaking professional specializing in medical translation (Pegorier Traductions, Paris, France). This assistance was funded by the authors.
